Clinical Trials Browser

Phase 1 × Head and Neck Neoplasms × Alpelisib × Clear all

NCT02051751 2020-12-08

A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer

Phase 1 Completed

BreastHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Neoplasms